APLT
Price
$0.27
Change
-$0.64 (-70.33%)
Updated
Nov 13 closing price
Capitalization
40.37M
119 days until earnings call
Intraday BUY SELL Signals
MLTX
Price
$12.56
Change
-$0.21 (-1.64%)
Updated
Nov 13 closing price
Capitalization
889.84M
104 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APLT vs MLTX

Header iconAPLT vs MLTX Comparison
Open Charts APLT vs MLTXBanner chart's image
Applied Therapeutics
Price$0.27
Change-$0.64 (-70.33%)
Volume$44.85M
Capitalization40.37M
MoonLake Immunotherapeutics
Price$12.56
Change-$0.21 (-1.64%)
Volume$2.38M
Capitalization889.84M
APLT vs MLTX Comparison Chart in %
APLT
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
APLT vs. MLTX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLT is a Hold and MLTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (APLT: $0.27 vs. MLTX: $12.56)
Brand notoriety: APLT and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLT: 616% vs. MLTX: 39%
Market capitalization -- APLT: $40.37M vs. MLTX: $889.84M
APLT [@Biotechnology] is valued at $40.37M. MLTX’s [@Biotechnology] market capitalization is $889.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLT’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 1 green FA rating(s).

  • APLT’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, APLT is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLT’s TA Score shows that 5 TA indicator(s) are bullish while MLTX’s TA Score has 5 bullish TA indicator(s).

  • APLT’s TA Score: 5 bullish, 5 bearish.
  • MLTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than APLT.

Price Growth

APLT (@Biotechnology) experienced а -63.87% price change this week, while MLTX (@Biotechnology) price change was +22.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

APLT is expected to report earnings on Mar 13, 2026.

MLTX is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($890M) has a higher market cap than APLT($40.4M). APLT YTD gains are higher at: -68.465 vs. MLTX (-76.417). APLT has higher annual earnings (EBITDA): -110.99M vs. MLTX (-196.98M). MLTX has more cash in the bank: 425M vs. APLT (30.4M). APLT has less debt than MLTX: APLT (2.6M) vs MLTX (75.8M). APLT has higher revenues than MLTX: APLT (121K) vs MLTX (0).
APLTMLTXAPLT / MLTX
Capitalization40.4M890M5%
EBITDA-110.99M-196.98M56%
Gain YTD-68.465-76.41790%
P/E RatioN/AN/A-
Revenue121K0-
Total Cash30.4M425M7%
Total Debt2.6M75.8M3%
FUNDAMENTALS RATINGS
APLT: Fundamental Ratings
APLT
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLTMLTX
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 3 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 3 days ago
69%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
68%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 26 days ago
90%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 29 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 3 days ago
75%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
APLT
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CERT8.410.13
+1.57%
Certara
BABA159.841.93
+1.22%
Alibaba Group Holding Limited
JHG43.75-0.72
-1.62%
Janus Henderson Group plc
TOI3.08-0.35
-10.20%
Oncology Institute (The)
SURG2.01-0.43
-17.49%
SurgePays

APLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLT has been loosely correlated with MLTX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APLT jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLT
1D Price
Change %
APLT100%
-70.33%
MLTX - APLT
36%
Loosely correlated
-1.64%
AMGXF - APLT
33%
Loosely correlated
N/A
KALA - APLT
33%
Loosely correlated
-9.43%
LRMR - APLT
30%
Poorly correlated
-2.37%
CRNX - APLT
30%
Poorly correlated
-3.25%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+8.68%
KALA - MLTX
88%
Closely correlated
-2.55%
IOBT - MLTX
75%
Closely correlated
-6.00%
NEVPF - MLTX
70%
Closely correlated
N/A
XNCR - MLTX
50%
Loosely correlated
-3.23%
NUVL - MLTX
48%
Loosely correlated
+0.91%
More